Syncom Healthcare Limited announced audited standalone earnings results for the fourth quarter and full year and consolidated earnings results for the full year ended March 31, 2018. For the quarter, on standalone basis, the company announced revenue from operations of INR 119.829 million compared to INR 70.913 million a year ago. Loss before exceptional items and tax was INR 1.901 million compared to INR 33.401 million a year ago. Total loss before tax was INR 2.861 million compared to INR 69.602 million a year ago. Total loss for the period was INR 2.861 million or INR 0.05 per basic and diluted share from continuing operations compared to INR 148.688 million or INR 3.72 per basic and diluted share from continuing operations a year ago. For the full year, on standalone basis, the company announced revenue from operations of INR 418.456 million compared to INR 533.476 million a year ago. Loss before exceptional items and tax was INR 87.905 million compared to INR 77.146 million a year ago. Total loss before tax was INR 655.232 million compared to INR 699.027 million a year ago. Total loss for the period was INR 655.232 million or INR 16.38 per basic and diluted share from continuing operations compared to INR 778.113 million or INR 19.47 per basic and diluted share from continuing operations a year ago. For the full year, on consolidated basis, the company announced revenue from operations of INR 418.456 million compared to INR 556.694 million a year ago. Loss before exceptional items and tax was INR 582.763 million compared to INR 916.628 million a year ago. Total loss before tax was INR 1,150.090 million compared to INR 1,538.509 million a year ago. Net loss for the period from continuing operations was INR 1,150.090 million or INR 28.75 per basic and diluted share from continuing operations compared to INR 1,529.545 million or INR 40.46 per basic and diluted share from continuing operations a year ago.